P38

Canadian Propane Association celebrates the best of the industry

Retrieved on: 
Thursday, May 19, 2022
DOT, CPA, Communication, Propane, Risk, WCB, Rego, Mentorship, Superior Propane Centre, Environment, Health, Solution, P38, DI, PSG, LPG, Environmental emergency, Industry, Marketing, Life, Time, Student, Safety, Organization, Technology, Chicago Innovation Awards, List of lifetime achievement awards, GLOBE, Relief valve, National Directorate for Personal Data Protection, Renewable energy, Tax advisor

CALGARY, Alberta, May 19, 2022 (GLOBE NEWSWIRE) -- The Canadian Propane Association (CPA) is pleased to announce the winners of its top industry awards at its 2022 Leadership Summit.

Key Points: 
  • CALGARY, Alberta, May 19, 2022 (GLOBE NEWSWIRE) -- The Canadian Propane Association (CPA) is pleased to announce the winners of its top industry awards at its 2022 Leadership Summit.
  • Two founding members of the Canadian Propane Association who made significant and consistent outstanding contributions to the advancement of the Canadian propane industry receive the 2022 Lifetime Achievement Award.
  • David Karn, president of family-owned Dowler-Karn Limited, is celebrated for his years of dedication to the propane industry, working to continually improve the standards and safety of the industry.
  • About the Canadian Propane Association:
    With over 400 members, the Canadian Propane Association (CPA) is the national association for a growing, multi-billion-dollar industry that impacts the livelihood of tens of thousands of Canadians.

2021 P38 Mitogen - Activated Protein (MAP) Kinase Inhibitors Pipeline Insight Report - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 30, 2021
Health, Pharmaceutical, DUX4, Administration, MAP, Muscle, Clinical trial, FDA, Losmapimod, Route, III, Fulcrum, Muscular dystrophy, Food, News, Pfizer, FSHD, Discovery, Therapy, Review, II, Patient, ROA, MAPK, Route of administration, GSK, Food and Drug Administration, Pharmaceutical industry, Fine chemical, P38

The "P38 Mitogen - Activated Protein (MAP) Kinase Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "P38 Mitogen - Activated Protein (MAP) Kinase Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P38 mitogen-activated protein (MAP) kinase inhibitors pipeline landscape.
  • P38 mitogen-activated protein (MAP) kinase inhibitors: Therapeutic Assessment
    This segment of the report provides insights about the different P38 mitogen-activated protein (MAP) kinase inhibitors drugs segregated based on following parameters that define the scope of the report, such as:
    There are approx.
  • P38 mitogen-activated protein (MAP) kinase inhibitors pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.